COM:DENALITHERAPEUTICS
Denali Therapeutics Inc
- Stock
Last Close
24.22
22/11 21:00
Market Cap
3.09B
Beta: -
Volume Today
814.16K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -232K - | -4.50M 1,841.81% | -4.27M 5.15% | -2.50M - | ||||||
average payables | 1.84M - | 2.34M 27.29% | 2.30M 1.54% | 2.24M 2.73% | 1.83M 18.30% | 2.92M 59.79% | 3.78M 29.38% | 6.14M 62.15% | ||
average receivables | 219K - | 451K 105.94% | 4.50M 898.89% | 4.27M 5.15% | 2.84M 33.61% | 3.45M 21.61% | 613K 82.23% | 2.50M 307.83% | ||
book value per share | -5.20 - | 39.62 861.80% | 31.13 21.43% | 5.90 81.03% | 4.13 30.04% | 10.56 155.62% | 7.92 25.00% | 8.30 4.87% | 0.01 99.91% | |
capex per share | -1.02 - | -0.95 6.26% | -0.19 79.88% | -0.04 80.93% | -0.19 411.62% | -0.03 84.85% | -0.07 146.27% | -0.14 103.10% | -0.00 99.93% | |
capex to depreciation | -25.31 - | -4.18 83.50% | -0.93 77.66% | -0.46 50.95% | -2.24 390.05% | -0.36 83.82% | -0.99 172.65% | -1.72 73.63% | 0.48 127.67% | |
capex to operating cash flow | 0.20 - | 0.08 58.33% | 0.04 55.75% | -0.07 280.47% | 0.12 274.61% | -0.01 106.29% | 0.04 640.66% | 0.07 81.23% | 0.04 50.40% | |
capex to revenue | -0.03 - | -0.67 2,456.85% | -0.01 98.63% | -0.17 1,794.42% | -0.16 5.88% | -0.04 76.19% | ||||
cash per share | 10.22 - | 27.76 171.46% | 27.15 2.20% | 5.01 81.53% | 4.34 13.34% | 13.49 210.44% | 7.12 47.20% | 10.64 49.48% | 0.01 99.93% | |
days of inventory on hand | ||||||||||
days payables outstanding | ||||||||||
days sales outstanding | 24.15 - | 6.17 - | 9.20 49.05% | |||||||
debt to assets | 0.03 - | 0.13 354.67% | 0.04 67.26% | 0.05 6.19% | 0.04 9.33% | 0.04 5.68% | ||||
debt to equity | 0.03 - | 0.18 426.19% | 0.06 67.41% | 0.07 11.13% | 0.06 12.96% | 0.04 24.64% | ||||
dividend yield | ||||||||||
earnings yield | -0.26 - | -0.63 141.53% | -0.38 40.07% | -0.02 94.97% | -0.12 526.51% | 0.01 106.57% | -0.05 787.92% | -0.09 74.18% | -0.00 99.95% | |
enterprise value | 33.75M - | 97.96M 190.27% | 15.66M 84.01% | 1.84B 11,623.84% | 1.65B 9.89% | 8.68B 424.78% | 5.19B 40.30% | 3.33B 35.71% | 2.95T 88,337.41% | |
enterprise value over ebitda | -2.04 - | -1.14 44.09% | -0.17 84.75% | -39.60 22,689.33% | -7.76 80.40% | 138.47 1,883.79% | -17.53 112.66% | -10.09 42.45% | -14.99K 148,432.89% | |
ev to operating cash flow | -2.24 - | -1.35 39.62% | -0.20 84.90% | 36.64 18,027.54% | -10.92 129.79% | 20.87 291.14% | -24.53 217.54% | -13.62 44.47% | -8.23K 60,354.17% | |
ev to sales | 14.22 - | 62.03 336.29% | 25.87 58.29% | 106.56 311.83% | 30.73 71.16% | 8.92K 28,920.54% | ||||
free cash flow per share | -6.03 - | -12.22 102.77% | -5.31 56.51% | 0.50 109.49% | -1.77 451.44% | 3.79 313.81% | -1.81 147.74% | -2.09 15.59% | -0.00 99.87% | |
free cash flow yield | -0.28 - | -0.57 102.77% | -0.34 40.35% | 0.02 107.19% | -0.10 516.80% | 0.05 144.47% | -0.04 189.65% | -0.08 85.38% | -0.00 99.83% | |
graham net net | -7.18 - | 25.23 451.57% | 25.76 2.07% | 3.79 85.27% | 2.69 29.12% | 9.36 248.26% | 3.49 62.69% | 7.32 109.47% | 0.01 99.91% | |
graham number | 25.56 - | 109.64 328.95% | 64.24 41.41% | 7.21 88.78% | 13.86 92.24% | 12.45 10.15% | 20.64 65.75% | 22.03 6.72% | 0.01 99.94% | |
income quality | 0.90 - | 0.84 6.86% | 0.87 4.07% | -1.38 259.13% | 0.77 155.47% | 5.85 662.69% | 0.73 87.56% | 0.75 3.19% | 2.47 228.38% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -46.11 - | -14.01 - | -23.06 - | |||||||
interest debt per share | 0.13 - | 0.21 57.74% | 0.92 345.35% | 0.63 31.15% | 0.53 16.65% | 0.60 13.62% | 0.00 99.95% | |||
inventory turnover | ||||||||||
invested capital | 0.03 - | 0.18 426.19% | 0.06 67.41% | 0.07 11.13% | 0.06 12.96% | 0.04 24.64% | ||||
market cap | 64.49M - | 137.81M 113.70% | 234.04M 69.83% | 1.91B 717.63% | 1.67B 12.96% | 9.13B 448.05% | 5.42B 40.62% | 3.49B 35.59% | 2.95T 84,344.91% | |
net current asset value | -18.89M - | 165.41M 975.82% | 388.68M 134.99% | 365.70M 5.91% | 271.69M 25.71% | 1.04B 283.49% | 455.36M 56.30% | 954.51M 109.61% | 941.17M 1.40% | |
net debt to ebitda | 1.86 - | 0.46 75.03% | 2.42 422.57% | 1.66 31.35% | 0.05 97.01% | -7.06 14,326.10% | 0.79 111.25% | 0.48 39.91% | 0.42 12.53% | |
net income per share | -5.58 - | -13.49 141.53% | -5.89 56.31% | -0.39 93.36% | -2.07 428.26% | 0.65 131.58% | -2.39 466.30% | -2.60 8.61% | -0.00 99.96% | |
operating cash flow per share | -5.01 - | -11.26 124.95% | -5.12 54.53% | 0.54 110.57% | -1.59 393.00% | 3.82 340.88% | -1.74 145.55% | -1.95 12.07% | -0.00 99.87% | |
payables turnover | ||||||||||
receivables turnover | 15.11 - | 59.16 - | 39.69 32.91% | |||||||
research and ddevelopement to revenue | 1.11 - | 7.25 553.88% | 0.63 91.26% | 5.45 760.89% | 3.31 39.35% | 1.28 61.23% | ||||
return on tangible assets | -0.46 - | -0.32 30.15% | -0.18 43.32% | -0.05 69.78% | -0.36 552.48% | 0.04 112.41% | -0.21 566.70% | -0.22 7.88% | -0.13 43.63% | |
revenue per share | 1.39 - | 0.28 79.99% | 3.08 1,003.87% | 0.40 87.00% | 0.86 115.78% | 0.00 99.72% | ||||
roe | 1.07 - | -0.34 131.71% | -0.19 44.39% | -0.07 65.00% | -0.50 655.12% | 0.06 112.36% | -0.30 588.39% | -0.31 3.56% | -0.14 54.96% | |
roic | 1.07 - | -0.34 132.20% | -0.19 45.64% | -0.10 43.86% | -0.40 278.47% | 0.05 112.17% | -0.27 663.28% | -0.29 7.68% | -0.18 40.12% | |
sales general and administrative to revenue | 0.25 - | 1.74 595.63% | 0.18 89.68% | 1.62 803.99% | 0.83 48.66% | 0.31 62.51% | ||||
shareholders equity per share | -5.20 - | 39.62 861.80% | 31.13 21.43% | 5.90 81.03% | 4.13 30.04% | 10.56 155.62% | 7.92 25.00% | 8.30 4.87% | 0.01 99.91% | |
stock based compensation to revenue | 0.15 - | 1.44 888.80% | 0.15 89.57% | 1.75 1,067.85% | 0.92 47.45% | 0.33 64.47% | ||||
tangible asset value | -15.63M - | 254.52M 1,727.98% | 465.80M 83.01% | 546.85M 17.40% | 394.89M 27.79% | 1.15B 191.35% | 962.29M 16.36% | 1.04B 8.33% | 1.03B 1.10% | |
tangible book value per share | -5.20 - | 39.62 861.80% | 31.13 21.43% | 5.90 81.03% | 4.13 30.04% | 10.56 155.62% | 7.92 25.00% | 8.30 4.87% | 0.01 99.91% | |
working capital | 29.95M - | 172.85M 477.13% | 395.44M 128.78% | 448.05M 13.30% | 384.69M 14.14% | 1.42B 270.16% | 518.99M 63.55% | 1.01B 94.30% | 986.15M 2.21% |
All numbers in USD (except ratios and percentages)